RUNX1 and clear cell adenocarcinoma: Laronda et al. used a mouse model to confirm that downregulation of RUNX family transcription factor 1 (RUNX1) and inhibition of the BMP/Activin SMAD signaling pathway were key molecular mechanisms underlying DES-induced vaginal adenosis and even clear cell adenocarcinoma [292].